These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7378013)

  • 41. Metastatic tumor to the retina and vitreous cavity from primary melanoma of the skin: treatment with systemic and subconjunctival chemotherapy.
    Robertson DM; Wilkinson CP; Murray JL; Gordy DD
    Ophthalmology; 1981 Dec; 88(12):1296-1301. PubMed ID: 7322479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemohormone therapy of metastatic melanoma with megestrol acetate plus dacarbazine, carmustine, and cisplatin.
    Nathanson L; Meelu MA; Losada R
    Cancer; 1994 Jan; 73(1):98-102. PubMed ID: 8275444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental ocular malignant melanoma in Sinclair swine.
    Burns RP; Tidwell M
    Curr Eye Res; 1986 Apr; 5(4):257-62. PubMed ID: 3519089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sub-choroidal implanted Greene melanoma: an animal experiment model for malignant choroid melanoma].
    Riedel KG; Svitra PP; Albert DM; Finger PT; Packer S
    Klin Monbl Augenheilkd; 1990 Aug; 197(2):128-32. PubMed ID: 2243472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
    Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
    Dykes DJ; Griswold DP; Schabel FM
    Cancer Res; 1976 Jun; 36(6):2031-4. PubMed ID: 1268854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iris melanoma in 12-year-old boy.
    Tran TA; Hirst LW; Axelsen RA; Welch R
    Clin Exp Ophthalmol; 2006 Jul; 34(5):489-90. PubMed ID: 16872348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma.
    Gajewski TF; Sosman J; Gerson SL; Liu L; Dolan E; Lin S; Vokes EE
    Clin Cancer Res; 2005 Nov; 11(21):7861-5. PubMed ID: 16278409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
    Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
    Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The morphology of the amelanotic Greene melanoma.
    Hahn I; Spitznas M
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(1):1-15. PubMed ID: 6909021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anterior vs posterior intraocular melanoma. Metastatic differences in a murine model.
    Grossniklaus HE; Wilson MW; Barron BC; Lynn MJ
    Arch Ophthalmol; 1996 Sep; 114(9):1116-20. PubMed ID: 8790099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Animal models for the study of uveal melanoma.
    Albert DM; Shadduck JA; Liu HS; Sunderman FW; Wagoner MD; Dohlman HG; Papale JJ
    Int Ophthalmol Clin; 1980; 20(2):143-60. PubMed ID: 6995384
    [No Abstract]   [Full Text] [Related]  

  • 53. Periocular topotecan for intraocular retinoblastoma.
    Mallipatna AC; Dimaras H; Chan HS; Héon E; Gallie BL
    Arch Ophthalmol; 2011 Jun; 129(6):738-45. PubMed ID: 21670340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Release of a nitrosourea derivative from refillable silicone rubber implants for the treatment of intraocular malignancies.
    Refojo MF; Liu HS; Leong FL; Sidebottom D
    J Bioeng; 1978; 2(5):437-45. PubMed ID: 744769
    [No Abstract]   [Full Text] [Related]  

  • 55. Tumors of the anterior uvea. I. Metastasizing malignant melanoma of the iris.
    Sunba MS; Rahi AH; Morgan G
    Arch Ophthalmol; 1980 Jan; 98(1):82-5. PubMed ID: 7352870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraocular use of rituximab.
    Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
    Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study.
    Raivio I
    Acta Ophthalmol Suppl; 1977; (133):1-64. PubMed ID: 196476
    [No Abstract]   [Full Text] [Related]  

  • 58. [Morphogenesis and malignancy of newly formed pigment in the choroid and ciliary body].
    Vit VV
    Oftalmol Zh; 1977; 32(4):295-300. PubMed ID: 896117
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of subconjunctivally administered antineoplastics on experimentally induced intraocular malignant tumour.
    Rootman J; Kumi C; Bussanich N; Damji K; Gudauskas G
    Can J Ophthalmol; 1989 Oct; 24(6):254-8. PubMed ID: 2611709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neovascular glaucoma after photoradiation therapy for uveal melanoma.
    Lewis RA; Tse DT; Phelps CD; Weingeist TA
    Arch Ophthalmol; 1984 Jun; 102(6):839-42. PubMed ID: 6203507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.